Pfizer will acquire Medivation for $81.50 per share in cash- an offer unlikely to be bested, says Brean Capital
Analyst Stephen Volkmann of Jefferies discussed Caterpillar Inc. (NYSE:CAT) after recently hosting investors for a plant tour and management meetings in Peoria, IL.
Analyst Rajvindra Gill of Needham & Company reiterated his Buy rating on Cirrus Logic, Inc. (NASDAQ:CRUS) with a price target of $55, marking …
Canaccord analyst Michael Walkley weighs in on shares of Qorvo Inc (NASDAQ:QRVO) after the wireless chip maker released its fiscal first-quarter results, posting revenues of …
US stocks are mostly higher in afternoon trading Friday, as investors worked through another mixed batch of corporate earnings. Among the equities in focus today …
Expedia Inc (NASDAQ:EXPE) shares are down nearly 3% to $116.15, after the online travel booking giant reported mixed second-qaurter results, with lower-than-expected revenue but higher EPS …
Roth Capital analyst Darren Aftahi weighs in on Glu Mobile Inc. (NASDAQ:GLUU) ahead of the company’s second-quarter earnings report on Tuesday, August 2.
Analyst William Power from Robert W. Baird maintained his Neutral rating on Fitbit Inc (NYSE:FIT) with a price target of $16, marking a 23% …
Advanced Micro Devices, Inc. (NASDAQ:AMD) shares rose nearly 10% to $5.
Galenica AG, specialty pharma giant owning Switzerland’s largest pharmacy network, is set to add drug-maker Relypsa Inc (NASDAQ:RLYP) to its beefed-up network, gaining …
